Ever Source Wealth Advisors, LLC Celldex Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,438 shares of CLDX stock, worth $28,084. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,438
Previous 1,285
11.91%
Holding current value
$28,084
Previous $32,000
18.75%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CLDX
# of Institutions
188Shares Held
69.3MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$163 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$127 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$91.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$76.1 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$73.3 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $913M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...